Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02943317
Title Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics and Preliminary Clinical Activity of Defactinib in Combination With Avelumab in Epithelial Ovarian Cancer
Recruitment Terminated
Gender female
Phase Phase I
Variant Requirements No
Sponsors Verastem, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Florida Cancer Specialists & Research Institute (FCS) Sarasota Florida 34232 United States Details
Dana Farber Cancer Instiyute Boston Massachusetts 02215 United States Details
Stephenson Cancer Center (University of Oklahoma) Oklahoma City Oklahoma 73104 United States Details
Sarah Cannon Research Institute at Tennessee Oncology Nashville Tennessee 37203 United States Details
Mary Crowley Cancer Research Centers Dallas Texas 75251 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field